About our Company
Resource Center

News

Interlace Medical Sponsors the World Congress Leadership Summit on the Business of Women’s Health in Boston, Massachusetts

Framingham, MA, June 8, 2010 - New Technology for Removing Submucosal Fibroids and Polyps Provides Increased Patient Satisfaction and Hospital Revenue. Interlace Medical will be showcasing its MyoSure™ Hysteroscopic Tissue Removal System for the treatment of submucosal fibroids at the World Congress Leadership Summit on the Business of Women’s Health June 9-11th at the Lenox Hotel in Boston.
go Read the Press Release (PDF)

Interlace Medical Initiates Clinical Trial of MyoSure™ for Office-Based Treatment of Submucosal Fibroids

Framingham, MA, March 30, 2010 - Interlace Medical, Inc. today announced that it has initiated a multi-center clinical trial of the MyoSure Hysteroscopic Tissue Removal System. The purpose of this study is to demonstrate that women experience minimal to no pain or discomfort during a MyoSure procedure when given a mild oral sedative together with a local anesthetic injected into the cervix.
go Read the Press Release (PDF)

FDA Clears Interlace Medical’s MyoSure™ Hysteroscopic Tissue Removal System for The Treatment of Submucosal Fibroids

Framingham, MA, October 28, 2009 (BUSINESS WIRE) - Interlace Medical, Inc., today announced that it has received 510K clearance from the U. S. Food and Drug Administration (FDA) to market the MyoSure Hysteroscopic Tissue Removal System for the removal of submucosal fibroids and polyps.
go Read the Press Release (PDF)

John P. McDonough Joins Interlace Medical’s Board of Directors

Framingham, MA, July 27, 2009 (BUSINESS WIRE) - Interlace Medical is pleased to announce that John P. McDonough has joined the company’s Board of Directors effective July 10th.
go Read the Press Release (PDF)

Interlace Medical Corporation Secures $20.5 Million

Framingham, MA, June 15, 2009 - Baird Venture Partners and HLM Venture Partners-led VC Syndicate Backs Leading Women’s Health Company
go Read the Press Release (PDF)

 

Events

AAGL - 38th Global Congress of Minimally Invasive Gynecology

Come visit us at Booth Number 219.
go Learn more